|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.265 USD | -1.37% |
|
-6.19% | -54.69% |
| 06-28 | ADMA Biologics, Inc.(NasdaqGM:ADMA) added to Russell 2000 Growth-Defensive Index | CI |
| 06-28 | ADMA Biologics, Inc.(NasdaqGM:ADMA) added to Russell 2000 Defensive Index | CI |
| Market Cap | 1.94B 1.71B 1.59B 1.46B 2.74B 188B 2.79B 18.98B 7.4B 91.74B 7.29B 7.13B 318B | P/E 2026 * |
10.3x | P/E 2027 * | 8.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.94B 1.71B 1.59B 1.46B 2.74B 188B 2.79B 18.98B 7.4B 91.74B 7.29B 7.13B 318B | EV / Sales 2026 * |
3.63x | EV / Sales 2027 * | 2.77x |
| Free-Float |
93.48% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ADMA Biologics, Inc.
| 22-12-07 | Wall Street lager gesloten | |
| 22-12-07 | Wall Street koerst af op vlak slot | |
| 22-12-07 | Wall Street verder omlaag bij opening | |
| 22-12-07 | Futures Wall Street wijzen omlaag | |
| 17-03-30 | Chinesischer Investor hat Interesse an Biotest |
| 1 day | -1.43% | ||
| 1 week | -6.19% | ||
| Current month | -1.25% | ||
| 1 month | -4.89% | ||
| 3 months | -25.41% | ||
| 6 months | -50.60% | ||
| Current year | -54.69% |
| 1 week | 8.19 |  | 8.94 |
| 1 month | 8.19 | | 9.33 |
| Current year | 7.21 | | 18.95 |
| 1 year | 7.21 | | 20.46 |
| 3 years | 3.06 | | 25.67 |
| 5 years | 1.01 | | 25.67 |
| 10 years | 1.01 | | 25.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 49 | 2011-09-30 |
Paul Kohler
DFI | Director of Finance/CFO | 49 | 2026-02-25 |
| Compliance Officer | 39 | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Lawrence Guiheen
BRD | Director/Board Member | 75 | 2012-07-23 |
Steven Elms
CHM | Chairman | 62 | 2012-03-29 |
Alison Finger
BRD | Director/Board Member | 62 | 2023-09-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/16/26 | Free | Chief Financial Officer | 221,493 | 0.0956% | ||
| 5/27/26 | Buy | Founder | 6,400 | 0.0028% | ||
| 5/12/26 | Buy | Founder | 12,500 | 0.0054% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.37% | -6.19% | -51.95% | +121.58% | 1.94B | |
| -0.11% | -4.30% | +13.51% | -10.65% | 66.25B | |
| -0.12% | +2.23% | +36.63% | +198.45% | 52.86B | |
| +0.51% | +37.90% | +37.90% | +37.90% | 43.01B | |
| -1.86% | -4.93% | -56.15% | -56.66% | 39.52B | |
| +1.85% | -3.79% | +53.47% | -27.43% | 29.19B | |
| +0.32% | -0.39% | +64.37% | +83.09% | 23.13B | |
| -1.89% | -9.52% | +64.81% | -53.55% | 23.04B | |
| -1.30% | -6.18% | +3.94% | +177.59% | 20.48B | |
| -1.04% | -1.59% | +66.57% | +124.27% | 16.6B | |
| Average | -0.38% | -2.25% | +23.31% | +59.46% | 31.6B | |
| Weighted average by Cap. | -0.23% | -1.60% | +24.90% | +47.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 534M 470M 437M 402M 753M 51.75B 766M 5.22B 2.04B 25.24B 2.01B 1.96B 87.56B | 701M 616M 572M 526M 987M 67.85B 1B 6.84B 2.67B 33.09B 2.63B 2.57B 115B |
| Net income | 194M 171M 159M 146M 273M 18.79B 278M 1.9B 739M 9.16B 728M 713M 31.8B | 250M 220M 205M 188M 353M 24.25B 359M 2.45B 954M 11.83B 940M 920M 41.03B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | US$8.265 | -1.37% | 1,215,683 |
| 26-07-22 | US$8.380 | -2.44% | 1,986,378 |
| 26-07-21 | US$8.590 | -1.83% | 2,579,079 |
| 26-07-20 | US$8.750 | +0.46% | 2,486,917 |
| 26-07-17 | US$8.710 | -1.14% | 5,589,556 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADMA Stock
Select your edition
All financial news and data tailored to specific country editions
